Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Memory impairment
|
48 | 0.614 | 0.360 | 4 | 89828149 | missense variant | C/T | snv | 0.020 | 1.000 | 2 | 2013 | 2019 | ||||||
Sleep Disorders
|
38 | 0.614 | 0.360 | 4 | 89828149 | missense variant | C/T | snv | 0.020 | 1.000 | 2 | 2013 | 2015 | ||||||
Sleep disturbances
|
74 | 0.614 | 0.360 | 4 | 89828149 | missense variant | C/T | snv | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||
[D]Sleep disturbances (& [hypersomnia] or [insomnia])
|
23 | 0.614 | 0.360 | 4 | 89828149 | missense variant | C/T | snv | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||
Behavioral Symptoms
|
9 | 0.614 | 0.360 | 4 | 89828149 | missense variant | C/T | snv | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||
Abnormal behavior
|
121 | 0.614 | 0.360 | 4 | 89828149 | missense variant | C/T | snv | 0.020 | 1.000 | 2 | 2010 | 2019 | ||||||
Adenomatous Polyposis Coli
|
237 | 0.614 | 0.360 | 4 | 89828149 | missense variant | C/T | snv | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||||
Amyloid Neuropathies, Familial
|
16 | 0.614 | 0.360 | 4 | 89828149 | missense variant | C/T | snv | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||||
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED
|
68 | 0.614 | 0.360 | 4 | 89828149 | missense variant | C/T | snv | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||||
Amyotrophic Lateral Sclerosis, Familial
|
68 | 0.614 | 0.360 | 4 | 89828149 | missense variant | C/T | snv | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||||
Progressive cGVHD
|
40 | 0.614 | 0.360 | 4 | 89828149 | missense variant | C/T | snv | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||||
Progressive Neoplastic Disease
|
40 | 0.614 | 0.360 | 4 | 89828149 | missense variant | C/T | snv | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||||
Secondary Parkinson Disease
|
1 | 0.614 | 0.360 | 4 | 89828149 | missense variant | C/T | snv | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||||
Huntington Disease
|
115 | 0.614 | 0.360 | 4 | 89828149 | missense variant | C/T | snv | 0.030 | 1.000 | 3 | 2007 | 2013 | ||||||
Mitochondrial abnormalities
|
20 | 0.614 | 0.360 | 4 | 89828149 | missense variant | C/T | snv | 0.010 | 1.000 | 1 | 2007 | 2007 | ||||||
Hyperactive behavior
|
112 | 0.614 | 0.360 | 4 | 89828149 | missense variant | C/T | snv | 0.040 | 1.000 | 4 | 2006 | 2018 | ||||||
Central neuroblastoma
|
231 | 0.614 | 0.360 | 4 | 89828149 | missense variant | C/T | snv | 0.050 | 1.000 | 5 | 2003 | 2018 | ||||||
Childhood Neuroblastoma
|
231 | 0.614 | 0.360 | 4 | 89828149 | missense variant | C/T | snv | 0.050 | 1.000 | 5 | 2003 | 2018 | ||||||
Neuroblastoma
|
386 | 0.614 | 0.360 | 4 | 89828149 | missense variant | C/T | snv | 0.050 | 1.000 | 5 | 2003 | 2018 | ||||||
PARKINSON DISEASE, LATE-ONSET
|
76 | 0.614 | 0.360 | 4 | 89828149 | missense variant | C/T | snv | 0.020 | 1.000 | 2 | 2003 | 2017 | ||||||
Movement Disorders
|
247 | 0.614 | 0.360 | 4 | 89828149 | missense variant | C/T | snv | 0.030 | 1.000 | 3 | 2002 | 2006 | ||||||
Neurodegenerative Disorders
|
85 | 0.614 | 0.360 | 4 | 89828149 | missense variant | C/T | snv | 0.020 | 1.000 | 2 | 2002 | 2003 | ||||||
Fibrillation
|
8 | 0.614 | 0.360 | 4 | 89828149 | missense variant | C/T | snv | 0.070 | 1.000 | 7 | 2001 | 2018 | ||||||
Parkinsonian Disorders
|
95 | 0.614 | 0.360 | 4 | 89828149 | missense variant | C/T | snv | 0.070 | 0.857 | 7 | 2001 | 2019 | ||||||
Sporadic Parkinson disease
|
65 | 0.614 | 0.360 | 4 | 89828149 | missense variant | C/T | snv | 0.040 | 1.000 | 4 | 2001 | 2020 |